1.34
Biomea Fusion Inc Aktie (BMEA) Neueste Nachrichten
Stop Loss: Is Biomea Fusion Inc. stock near bottom after declineDollar Strength & Advanced Swing Trade Entry Alerts - ulpravda.ru
Is Biomea Fusion Inc. stock near bottom after decline2025 Short Interest & Real-Time Price Movement Reports - ulpravda.ru
Will Biomea Fusion Inc. stock return to pre crisis levels2026 world cup usa national team round of 16 key players build up play expert forecast preview - ulpravda.ru
Biomea Fusion looks to major milestones in 2026 - Traders Union
Biomea Fusion downgraded to Underweight from Neutral at JPMorgan - MSN
Biomea Fusion Inc. (BMEA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Biomea Fusion, Inc. (NASDAQ:BMEA) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Biomea Fusion explores challenges of insulin therapy - Traders Union
Can Biomea Fusion Inc. stock outperform in 2025 bull marketCEO Change & Detailed Earnings Play Strategies - Улправда
Published on: 2025-12-20 18:19:39 - Улправда
How interest rate cuts could boost Biomea Fusion Inc. stockWeekly Stock Recap & Daily Momentum Trading Reports - Улправда
Published on: 2025-12-20 15:52:57 - Улправда
Will Biomea Fusion Inc. stock split attract more investors2025 Technical Overview & Technical Entry and Exit Alerts - DonanımHaber
Published on: 2025-12-19 02:18:12 - Улправда
Aug Closing: Will Biomea Fusion Inc. stock outperform growth indexesJuly 2025 Action & Risk Controlled Swing Alerts - Улправда
Gap Down: Can Biomea Fusion Inc. stock outperform in 2025 bull market - Улправда
Biomea Fusion, Inc.(NasdaqGS: BMEA) dropped from NASDAQ Biotechnology Index - marketscreener.com
Biomea Fusion to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Upcoming EventsBiomea Fusion to Present at the 44th Annual J.P. Morgan Healthcare Conference - FinancialContent
Biomea Fusion presents COVALENT-111 study results at WCIRDC - MSN
Insider Buying: Biomea Fusion (NASDAQ:BMEA) Insider Acquires 30,000 Shares of Stock - MarketBeat
Biomea Fusion Director Rainer M Erdtmann Acquires 30,000 Shares - TradingView — Track All Markets
[Form 4] Biomea Fusion, Inc. Insider Trading Activity - Stock Titan
JANUS HENDERSON GROUP PLC Acquires Significant Stake in Biomea F - GuruFocus
Interim CEO & Director of Biomea Fusion Michael J. Hitchcock Buys 667% More Shares - simplywall.st
Biomea Fusion Announces KOL Presentation and Interview on Menin and Icovamenib at WCIRDC 2025 - The Manila Times
Biomea Fusion Highlights the Future of Menin Inhibitors and Icovamenib in Interview with Dr. Ralph DeFronzo at WCIRDC 2025 - Quiver Quantitative
Biomea Fusion (Nasdaq: BMEA) features KOL talk on menin, icovamenib at WCIRDC 2025 - Stock Titan
Biomea Fusion : WCIRDC 2025 COVALENT 111 Week 52 final Oral Presentation - marketscreener.com
Is Biomea Fusion Inc a good long term investmentEarnings Revision Updates & High Profit Market Growth - earlytimes.in
Biomea Fusion reports durable effects of diabetes drug 9 months after dosing - Investing.com Nigeria
Biomea Fusion (BMEA) Stock Jumps on Durable Diabetes Drug Data: Outlook, Analyst Targets and Key Risks as of December 5, 2025 - ts2.tech
Biomea Fusion Showcases Durable Benefits Of Menin Inhibitor In Type-2 Diabetes - RTTNews
Biomea Fusion stock soars after durable diabetes treatment results By Investing.com - Investing.com Nigeria
Biomea Fusion stock soars after durable diabetes treatment results - Investing.com
Biomea Fusion reports durable effects of diabetes drug 9 months after dosing By Investing.com - Investing.com South Africa
Biomea Fusion Presents Promising Results for Icovamenib in Treating Type 2 Diabetes at WCIRDC 2025 - Quiver Quantitative
Biomea Fusion Presents COVALENT-111 Study Results at the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC) - The Manila Times
Is Biomea Fusion Inc. stock a buy before product launchesEarnings Recap Report & Weekly Top Gainers Alerts - Newser
BMEA Insider Trading - Quiver Quantitative
Biomea Fusion Interim CEO Increases Stake with 100,000 Shares Purchase - TradingView
BMEA: Advancing Menin and oral GLP-1 therapies for diabetes, with phase II trials and strong financial runway - TradingView — Track All Markets
Biomea Fusion (BMEA) Stock Analysis Report | Financials & Insights - Benzinga
Biomea Fusion Director Rainer M Erdtmann Acquires 50,000 Shares - TradingView — Track All Markets
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):